- freely available
Mar. Drugs 2013, 11(5), 1524-1533; doi:10.3390/md11051524
Abstract: Two new oxazole/thiazole derivatives, named tetroazolemycins A (1) and B (2), have been isolated from the acetone extract of the mycelium of Streptomyces olivaceus FXJ8.012 derived from deep-sea water, together with three known compounds, spoxazomicins A–C (3–5), isolated from the fermentation supernatant. The planar structure and relative configuration of tetroazolemycins were elucidated by a combination of spectroscopic analyses, including 1D- and 2D-NMR techniques, and showed to be new pyochelin-type antibiotics. Both compounds showed metal ion-binding activity and their Zn2+ complexes exhibited weak activity against pathogenic bacteria Klebsiella pneumoniae.
Actinomycetes, representing one of the most proliﬁc sources for the discovery of bioactive natural products [1,2], have led to the finding of over 50% antibiotics  over the past 50 years, such as erythromycin, gentamicin, chloramphenicol, etc. The particularity and complexity of marine environments probably endow marine microorganisms the ability to produce different metabolites from those of their terrestrial counterparts [3,4], therefore, the potential for discovering new compounds from marine actinomycetes has been suggested to be far greater than that from terrestrial sources [5,6,7,8]. During our screening program for new natural products from marine actinomycetes, streptomycete strain FXJ8.012, which was isolated from a deep-sea water sample collected from southwest Indian Ocean, was found to produce interesting secondary metabolites besides lobophorins A and B (produced in another culture medium). Further investigation of the metabolites led to the discovery of five siderophores, including two new oxazole/thiazole derivatives (1–2) and spoxazomicins A–C (3–5) (Figure 1). Herein we describe the isolation and structural elucidation of the two new compounds, and their activities.
2. Results and Discussion
Strain FXJ8.012 formed brown substrate mycelia and abundant grey aerial spore mass after incubation on GYM agar  in petri dishes at 28 °C for 7 days. The 16S rRNA gene sequence of this strain was identical with that of Streptomyces olivaceus NBRC 12805T.
A crude product (1.6 g) was extracted from the mycelia of 12 L fermentation broth of strain FXJ8.012 and was further purified using Sephadex LH-20 column chromatography, preparative thin layer chromatography (PTLC) and preparative high-pressure liquid chromatography (HPLC) to yield compounds 1 (19.1 mg) and 2 (6.6 mg).
2.1. Structural Identification of Tetroazolemycins A and B from Streptomyces olivaceus FXJ8.012
Tetroazolemycin A (1) was obtained as pale yellow solid. Its molecular formula was established as C34H40N6O6S4 according to the [M + H]+ at m/z 757.1971 (Calcd for C34H41N6O6S4, 757.1970) of high resolution-electrospray ionization-mass spectrum (HR-ESI-MS) combined with the 13C-nuclear magnetic resonance (NMR) data and corresponding to eighteen degrees of unsaturation. The maxima at 243 and 303 nm in the ultraviolet (UV) spectrum and absorption bands at 1615, 1581, 1491 and 757 cm−1 in the infrared (IR) spectra exhibited the presence of ortho-substituted phenyl chromophore. Absorption bands at 1668 and 1639 cm−1 in the IR spectra also suggested the presence of >C=O ester and >C=N– groups respectively.
The 13C-NMR spectrum of tetroazolemycin A (1) showed only half of the expected carbon signals (Table 1), suggesting that this compound had symmetric substructures. The 1H-NMR, 13C-NMR and 2D-Heteronuclear Single Quantum Coherence (HSQC) spectra revealed the presences of an ortho-substituted phenyl (δ 6.97, 7.44, 6.92, 7.67 in 1H-NMR, bearing a coupling constant J = 7.8; δ 110.4, 160.1, 116.5, 133.6, 118.6, 128 in 13C-NMR), four methylene groups, four non-phenyl methine groups, and one methyl group (Table 1).
Detailed analysis of 2D-NMR spectra revealed that 1 was comprised of four ring structures, A–D: a hydroxyphenyl ring (A), an oxazoline ring (B), a thiazolidine ring (C) and a diketopiperazine ring (D) (Figure 2). The existence of ring A was previously inferred by UV, IR and 1D-NMR experiments, and was confirmed by 1H-1H correlation spectroscopy (COSY) and heteronuclear multiple bond correlation (HMBC) experiments: the proton spin system established from H-3 to H-6, the correlations from H-3, H-5 to C-1 and from H-4, H-6 to C-2. By the characteristic carbon signals of C-7 (δ 166.2), C-8 (δ 69.8) and C-9 (δ 71.4), the 1H-1H COSY correlation of H-8 and H-9, the HMBC correlation of H-8 to C-7, together with the absorption band at 1,639 cm−1 in the IR spectra, the substructure of ring B could be constructed as an oxazoline skeleton. The substructure C was deduced as N-methyl thiazolidine ring based on analysis of the characteristic carbon signals of C-10 (δ 78.5), C-11 (δ 34.2), C-12 (δ 70.4), COSY correlation (H-11 and H-12) and HMBC correlations from H-11 and H-12 to C-10. The existence of the N-methyl (δH 2.52 and δC 44.2) on ring C was sustained by the HMBC correlations from H-17 to C-10 and C-12, respectively. The HMBC correlations from H-13 to C-14 and C-16, from H-16 to C-14 and from H-15 to C-14′, together with the chemical shift of C-14 (δ 168.8) and 1H-1H COSY correlation of H-15 and H-16 suggested a diketopiperazine or an azetidine-2-one moiety of ring D. However, the S–S bond could not be reduced using β-mercaptoethanol and DTT, and MS/MS of the compounds did not give mass related to azethidine containing monomers (data not shown). Thus, ring D was deduced as a diketopiperazine containing structure.
|Position||δH||δC, mult.||Position||δH||δC, mult.||Position||δH||δC, mult.|
|1 and 1′||―||110.4, C||1||―||110.4, C||1′||―||110.4, C|
|2 and 2′||―||160.1, C||2||―||160.0, C||2′||―||160.0, C|
|3 and 3′||6.97 (d; 7.8)||116.5, CH||3||6.96 (d; 7.8)||116.5, CH||3′||6.96 (d; 7.8)||116.6, CH|
|4 and 4′||7.44 (dd; 7.8, 7.8)||133.6, CH||4||7.42 (dd; 7.8, 7.8)||133.7, CH||4′||7.42 (dd; 7.8, 7.8)||133.7, CH|
|5 and 5′||6.92 (dd; 7.8, 7.8)||118.6, CH||5||6.91 (dd; 7.8, 7.8)||118.6, CH||5′||6.91 (dd; 7.8, 7.8)||118.7, CH|
|6 and 6′||7.67 (d; 7.8)||128, CH||6||7.65 (d; 7.8)||128.0, CH||6′||7.63 (d; 7.8)||128.0, CH|
|7 and 7′||―||166.2, C=N||7||―||166.2, C=N||7′||―||166.2, C=N|
|8 and 8′-a||4.47 (m)||69.8, CH2||8-a||4.46 (m)||69.9, CH2||8′-a||4.29 (m)||69.3, CH2|
|8 and 8′-b||4.62 (m)||8-b||4.62 (m)||8′-b||4.53 (dd; 8.4, 9.6)|
|9 and 9′||4.62 (m)||71.4, CH||9||4.61 (m)||71.2, CH||9′||4.77 (m)||67.9, CH|
|10 and 10′||4.24 (d; 6.0)||78.5, CH||10||4.22 (d; 6.6)||78.6, CH||10′||4.62 (m)||77.1, CH|
|11 and 11′-a||2.90 (dd; 6.6, 11.4)||34.2, CH2||11-a||2.90 (m)||34.2, CH2||11′-a||2.77 (m)||32.6, CH2|
|11 and 11′-b||3.15 (dd; 6.6, 11.4)||11-b||3.18 (m)||11′-b||3.00 (m)|
|12 and 12′||3.49 (m)||70.4, CH||12||3.49 (m)||70.3, CH||12′||3.84 (m)||67.0, CH|
|13 and 13′-a||2.92 (dd; 7.2, 13.8)||47.4, CH2||13-a||2.90 (m)||47.5, CH2||13′-a||3.13 (m)||42.6, CH2|
|13 and 13′-b||4.05 (dd; 6.6, 13.8)||13-b||4.03 (m)||13′-b||4.05 (m)|
|14 and 14′||―||168.8, C=O||14||―||168.9, C=O||14′||―||169.3, C=O|
|15 and 15′||3.65 (d; 3.6)||45.4, CH2||15||3.64 (m)||45.4, CH2||15′||3.62 (m)||45.6, CH2|
|16 and 16′||4.75 (t; 3.8)||60.1, CH||16||4.78 (m)||60.2, CH||16′||4.75 (m)||59.4, CH|
|17 and 17′||2.52 (s)||44.2, CH3||17||2.54 (s)||44.4, CH3||17′||2.45 (s)||36.2, CH3|
The connectivities of substructures A–D were elucidated by the HMBC and 1H-1H COSY experiments (Figure 2). The connectivity between ring A and ring B was confirmed by the long-range coupling from H-6 to C-7. The HMBC correlation from H-8 to C-10 and COSY correlation of H-9 and H-10 established the linkage between ring B and ring C. The HMBC correlation from H-11 to C-13, from H-13 to C-14 and C-16, together with the COSY correlation of H-11/H-12/H-13, established the linkage between ring C and ring D. Considering the molecular formula, the remaining sulfur atom of 1 should be assigned to C-15 and C-15′ to form a S–S bond.
In the NOE difference experiments, an irradiation of H-10 resulted in the enhancement of H-12 and H-17, indicating that H-10 and H-12 were on one face of ring C and that H-9 and H-13 were on the other face. This deduction was further sustained by the correlations between H-9 and H-13a in a 2D-NOESY experiment (Figure 3, left). Irradiations of H-8a and H-8b both resulted in the enhancement of H-17, indicating that H-8 and H-17 were on the same side of the paper plane. Other Key NOE correlations were shown in Figure 3. Therefore, the relative configurations of C-9, C-10 and C-12 of compound 1 were proposed to be 9R*, 10S*, and 12S*. This proposal was sustained by the co-production of spoxazomicin A from a biogenetic perspective.
Tetroazolemycin B (2) was also obtained as pale yellow solid, and its molecular formula was established as C34H40N6O6S4 according to the [M + H]+ at m/z 757.1965 (Calcd for C34H41N6O6S4, 757.1970) in HR-ESI-MS combined with the 13C-NMR data and corresponding to eighteen degrees of unsaturation, too. It’s UV, IR, 1H- and 13C-NMR spectra were similar to those of tetroazolemycin A (1). Careful analysis of its 1H-NMR, 13C-NMR and 2D-NMR data revealed that half structure of this compound was identical with that of 1, and the planar structure of the other half was still in accordance with 1. Differences lied in the chemical shifts of carbons 8′ to 13′ and 17′, implying a different relative configuration of this half structure. Further 2D-NOESY revealed the correlation between H-9′ and H-12′ (Figure 3, right), suggesting that H-10′ and H-12′ were not on the same side of ring C. No correlation was found between H-8′ and H-17′ in 2D-NOESY experiment; and in the NOE difference experiment, neither the irradiation of H-8′ nor H-8′b resulted in the enhancement of H-17′, indicating that H-8′ and H-17′ were on the opposite side of the paper plane. Other Key NOE correlations were shown in Figure 3. Considering the co-production of spoxazomicin B and from a biogenetic perspective, the relative configurations of C-9, C-10 and C-12 of compound 2 were suggested as 9R*, 10S*, 12S*, 9′R*, 10′R*, and 12′S*.
2.2. The Activities of Compounds 1 and 2
Tetroazolemycins A (1) and B (2) were evaluated for their heavy metal ion-binding ability. When Fe3+, Cu2+ and Zn2+ solutions were added into tetroazolemycins A (1) and B (2)-acetone solutions, mauve, blue and white precipitates could be observed respectively and immediately, while no precipitation or color change occurred when Pb2+, Cr3+ or Mn2+ solutions were added. In reverse, when tetroazolemycin A (1) and B (2)-acetone solutions were added into the metal ion solutions, brown, blue and white precipitates could be observed immediately in Fe3+, Cu2+ and Zn2+ solutions respectively, while no precipitates or color change occurred in Pb2+, Cr3+ or Mn2+ solutions. These facts indicated that tetroazolemycins A (1) and B (2) had affinity for Fe3+, Cu2+ and Zn2+ but not for Cr3+, Mn2+ or Pb2+.
The compounds and their metal ion complexes turned out to be inactive against microbes Staphyloccocus aureus, Escherichia coli, Bacillus subtilis, Mycobacterium gilvum, Pseudomonas aeruginosa, Candida albicans, Candida pseudorugosa, Aspergillus fumigatus, Fusarium oxysporum and Rhizoctonia solani, inactive against P388D and A549 tumor cell lines, and inactive against influenza A H1N1 (A/WSN/33) virus. Although tetroazolemycins A (1) and B (2) showed no activity against Klebsiella pneumoniae either, their Zn2+ complexes weakly inhibited this pathogen with MICs of 125–250 µg/mL and 125 µg/mL, respectively.
Tetroazolemycins A (1) and B (2) are structurally classified as oxazole/thiazole siderophores with high affinity for ferric ion . A large number of siderophores with different types of structures have been isolated so far from microorganisms . The chemical structures of 1 and 2 are closely related to those of spoxazomicins , pyochelin , thiazostatin , wastemycins , and transvalencins . However, this is the first report of homo/hetero-dimer siderophores of pyochelin family antibiotics. It is hard to determine the absolute configurations for pyochelin-type siderophores due to their multi-chiral centers and isomerization on ring C, so most of the pyochelin-type siderophores, including spoxazomicins, were reported without absolute stereochemistry. We have not resolved the absolute configurations of tetroazolemycins either, for the structures contain neither available hydroxyl groups for Mosher’s reaction nor available amino acids for Marfey’s reaction, no CD spectra from reference compounds have been reported, and our effort for crystallizing tetroazolemycins and their metal ion complexes was failed.
Tetroazolemycins A (1) and B (2) are functionally unique owing to their binding ability to Fe3+, Cu2+ and Zn2+, like desferrioxamine E, which was also reported to be able to bind multiple metal ions besides Fe3+ . Because the antimicrobial activity is not exhibited by the free-state tetroazolemycins but by their Zn2+-complexes, like transvalencin A, and because the gene cluster of coelibactin, a putative pyochelin-type siderophore, was regulated by Zn2+ , we suppose that the oxazole/thiazole siderophores may be closely related to Zn2+ besides Fe3+, and the in situ function of them probably needs to be re-evaluated. On the other hand, tetroazolemycins A (1) and B (2) are sulfur-containing compounds. As many sulfur-containing natural products, such as bleomycin, cyclothiazomycin, diphenazithionin, penicillin, etc., exhibit significant bioactivity, we speculate that tetroazolemycins possess potential bioactivities although no obvious antibiotic activity was detected in this study. Further studies on the absolute configuration and more pharmacological functions of tetroazolemycins are in progress.
3. Experimental Section
UV spectra were recorded on a Beckman Coulter DU800 UV/Vis Spectrophotometer, 190 to 800 nm. IR spectra were recorded on a Thermo Nicoiet 8,700 spectrometer. Optical rotation was run on an ATAGO POLAX-2L polarimeter. ESI-MS spectra were performed on a Thermo-Finnigan LCQ DECA XP mass spectrometer. HR-ESI-MS spectra were obtained on a Waters Xevo G2 QTOF mass spectrometer. NMR spectra were measured on a Bruker AV 600/400 NMR spectrometer. The concentration was performed on an EYELA N-1100S-W rotary evaporator. The analytical and preparative HPLC were both performed on a Shimadzu SPD-M20A HPLC system with a Waters Xbridge ODS (10 × 150 mm, 5 μm) column and a Sigma-aldrich Ascentis RP-Amide column (4.6 × 150 mm, 5 μm). Column chromatography was carried out on silica gel (100–200 mesh) (Qingdao Haiyang Chemical Group Corp., Qingdao, China) and Sephadex LH-20 (Pharmacia, Uppsala, Sweden). Thin layer chromatography (TLC) was carried out on silica gel GF254 plate (1.05554.0001, MERCK, Darmstadt, Germany). PTLC was carried out on silica gel GF254 preparative plate (Qingdao Haiyang Chemical Group Corp., Qingdao, China).
3.2. Actinomycete Strain
Streptomyce olivaceus FXJ8.012 was isolated from a deep-sea water sample collected from southwest Indian Ocean (S37.83°, E72.00°) at a depth of 3,838 m, during the DY115-20 cruise of DaYang YiHao research vessel in 2009. The isolation and growth media were both GYM agar. The strain was identified by morphology and 16S rRNA gene sequence analysis using regular procedures , and was deposited in the China General Microbiological Culture Collection Centre (CGMCC), Beijing, China, under the accession number CGMCC 4950.
3.3. Fermentation, Extraction and Isolation
After growth on GYM agar in petri dishes at 28 °C for 7 days, suitable amount of spores of Streptomyces olivaceus FXJ8.012 were transferred to a 500-mL shake ﬂask containing 100 mL of liquid GYM medium and incubated on a rotary shaker at 170–180 rpm and 28 °C for 5 days as the seed culture. The seed culture was used to inoculate 120 bottles of 500-mL shake ﬂasks each containing 100 mL of SGG medium , followed by incubation under similar conditions for 7 days.
After fermentation, the culture broth (12 L) was centrifugated at 5000 rpm for 15 min to separate the mycelia and supernatant. The resulting mycelium cake was extracted three times with equal volume acetone for three hours. The acetone-extracted portion was then concentrated in vacuo to evaporate the solvent, and subjected to silica gel (100–200 mesh) column chromatography using a gradient of CHCl3/MeOH (100%–90%) to obtain the crude product (1.6 g). The crude product was subjected to Sephadex LH-20 (MeOH) to get rid of fatty acids, nucleosides and other impurities. PTLC (20 × 20 cm, CHCl3:MeOH = 10:1.2) was followed to obtain fraction I (41 mg). Final purification was carried out sequentially by the RP-HPLC with Waters Xbridge ODS column (MeOH:H2O = 70:30, v/v) and Sigma-aldrich Ascentis RP-Amide column (MeOH:H2O = 64:36, v/v) to yield 1 (19.1 mg) and 2 (6.6 mg).
After concentrated in vacuo to about 3 L, the fermentation supernatant was extracted three times with equal volume ethyl acetate. The ethyl acetate portion was then concentrated in vacuo to evaporate the solvent, and subjected to silica gel (100–200 mesh) column chromatography using a gradient of CHCl3/MeOH (100%–90%) to obtain the crude product (0.5 g). The crude product was subjected to Sephadex LH-20 (MeOH), and further purified sequentially by the RP-HPLC with Waters Xbridge ODS column (MeOH:H2O = 80:20, v/v) and Sigma-aldrich Ascentis RP-Amide column (Acetonitrile:H2O = 65:35, v/v) to yield 3 (3.3 mg), 4 (1.3 mg) and 5 (0.7 mg).
Tetroazolemycin A (1): pale yellow solid; [α]25D (c 0.1, MeOH) = −10.7°; UV (MeOH, c = 0.05) λmax (log ε) 242 (1.13), 304 (0.88) nm; IR (KBr) νmax 3431, 3060, 2926, 2856, 1668, 1639, 1615, 1581, 1491, 1460, 1367, 1258, 1231, 757.1 cm−1; 1H- and 13C-NMR data, Table 1; ESI-MS m/z 757 [M + H]+, 779 [M + Na]+; HR-ESI-MS m/z 757.1971 [M + H]+ (Calcd for C34H41N6O6S4, 757.1970) (see supplementary Figures S1–S13).
Tetroazolemycin B (2): pale yellow solid; [α]25D (c 0.03, MeOH) = −17.4°; UV (MeOH, c = 0.05) λmax (log ε) 241 (1.11), 304 (0.84) nm; IR (KBr) νmax 3434, 3064, 2926, 2858, 1669, 1640, 1615, 1581, 1491, 1460, 1367, 1258, 1230, 758 cm−1; 1H- and 13C-NMR data, Table 1; ESI-MS m/z 757 [M + H]+, 779 [M + Na]+; HR-ESI-MS m/z 757.1965 [M + H]+ (Calcd for C34H41N6O6S4, 757.1970) (see supplementary Figures S14–S23).
Spoxazomicin A (3): yellow solid; UV (MeOH:H2O 70:30) 242, 301 nm; 1H- and 13C-NMR data, supplementary Table S1; HR-ESI-MS m/z 336.1384 [M + H]+ (Calcd for C16H21N3O3S, 336.1382) (see supplementary Figures S24–S26).
Spoxazomicin B (4): yellow solid; UV (MeOH:H2O 70:30) 242, 301 nm; 1H- and 13C-NMR data, Table S1. HR-ESI-MS m/z 336.1385 [M + H]+ (Calcd for C16H21N3O3S, 336.1382) (see supplementary Figures S27–S29).
3.4. Metal Ion Binding Assay
0.1 M solutions of FeCl3, CuSO4, ZnCl2, PbCl2, CrCl3 and MnCl2 were prepared fresh. Several microliters of each solution were added into 0.5–1 mL tetroazolemycins A (1) and B (2)-acetone solutions respectively, and vice versa. Metal ion binding ability was determined by observing the precipitation of the complexes and color change of the solutions.
3.5. Bioactivity Assay
Primary antimicrobial assays were conducted using agar-diffusion method: 50 µg compound solution was transferred to a sterile filter paper disc of 5 mm diameter, and put onto the surface of LB agar  or PDA agar  containing pathogenic bacteria or fungi, followed by incubation at 37 °C overnight for bacteria or 25 °C for 1–2 days for fungi. Bioactivity was determined by observing the inhibition zone. MIC assays were conducted in triplicate using liquid cultures in 96-well culture plates according to a modified method described by Shapiro .
Antitumor activity was tested against murine macrophage cell line P388D and human lung adenocarcinoma cell line A549, using MTT method as described previously . The result of anti-influenza A H1N1 (A/WSN/33) virus was provided by professor Xin Ye at the Institute of Microbiology, Chinese Academy of Sciences (IMCAS).
Five oxazole/thiazole siderophores 1–5 were isolated from marine Streptomyces olivaceus FXJ8.012 and their structures were elucidated. The major compounds tetroazolemycins A (1) and B (2) represent novel chemical structures and are the first discovered dimer forms of pyochelin-type siderophores. Tetroazolemycins showed affinity for Fe3+, Cu2+ and Zn2+, and the Zn2+ complexes of 1 and 2 weakly inhibited pathogen Klebsiella pneumoniae.
We thank Xuejun Jiang and Xin Ye at the IMCAS for antitumor assay and anti-influenza virus test, respectively. This work was supported by the program of China Ocean Mineral Resources R & D Association (grant no. DYXM-115-02-1-02), the National Basic Research Program of China (grant no. 2011CB808800), and by the Knowledge Innovation Program of Chinese Academy of Sciences (grant no. KSCX2-EW-J-6/KSCX2-EW-G-12B).
References and Notes
- Baltz, R.H. Antimicrobials from actinomycetes: Back to the future. Microbe 2007, 2, 125–131. [Google Scholar]
- Bérdy, J. Bioactive microbial metabolites. J. Antibiot. 2005, 58, 1–26. [Google Scholar] [CrossRef]
- Lam, S.K. Discovery of novel metabolites from marine actinomycetes. Curr. Opin. Microbiol. 2006, 9, 245–251. [Google Scholar] [CrossRef]
- Zhang, L.X.; An, R.; Wang, J.P.; Sun, N.; Zhang, S.; Hu, J.C.; Kuai, J. Exploring novel bioactive compounds from marine microbes. Curr. Opin. Microbiol. 2005, 8, 276–281. [Google Scholar] [CrossRef]
- Blunt, J.W.; Copp, B.R.; Hu, W.P.; Munro, M.H.G.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2008, 25, 35–94. [Google Scholar] [CrossRef]
- Blunt, J.W.; Copp, B.R.; Hu, W.P.; Munro, M.H.G.; Northcote, P.T.; Prinsep, M.R. Marine natural products. Nat. Prod. Rep. 2009, 26, 170–244. [Google Scholar] [CrossRef]
- Bugni, T.S.; Ireland, C.M. Marine-derived fungi: A chemically and biologically diverse group of microorganisms. Nat. Prod. Rep. 2004, 21, 143–163. [Google Scholar] [CrossRef]
- Saleem, M.; Ali, M.S.; Hussain, S.; Jabbar, A.; Ashraf, M.; Lee, Y.S. Marine natural products of fungal origin. Nat. Prod. Rep. 2007, 24, 1142–1152. [Google Scholar] [CrossRef]
- GYM-agar (1000 mL): yeast extract (4 g, Oxoid), malt extract (4 g, Bacto), glucose (10 g), CaCO3 (2 g) and agar (15 g).
- Boukhalfa, H.; Crumbliss, A.L. Chemical aspects of siderophore mediated iron transport. BioMetals 2002, 15, 325–339. [Google Scholar] [CrossRef]
- Dictionary of Natural Products on DVD; Chapman & Hall Ltd.: London, UK, 2010.
- Inahashi, Y.; Iwatsuki, M.; Ishiyama, A.; Namatame, M.; Nishihara-Tsukashima, A.; Matsumoto, A.; Hirose, T.; Sunazuka, T.; Yamada, H.; Otoguro, K.; et al. Spoxazomicins A–C, novel antitrypanosomal alkaloids produced by an endophytic actinomycete, Streptosporangium oxazolinicum K07–0460T. J. Antibiot. 2011, 64, 303–307. [Google Scholar] [CrossRef]
- Rinehart, K.L.; Staley, A.L.; Wilson, S.R.; Ankenbauer, R.G.; Cox, C.D. Stereochemical assignment of the pyochelins. J. Org. Chem. 1995, 60, 2786–2791. [Google Scholar]
- Shindo, K.; Takenaka, A.; Noguchi, T.; Hayakawa, Y.; Seto, H. Thiazostatin A and thiazostatin B, new antioxidants produced by Streptomyces tolurosus. J. Antibiot. 1989, 42, 1526–1529. [Google Scholar] [CrossRef]
- Sasaki, T.; Igarashi, Y.; Saito, N.; Furumai, T. Watasemycins A and B, new antibiotics produced by Streptomyces sp. TP-A0597. J. Antibiot. 2002, 55, 249–255. [Google Scholar] [CrossRef]
- Hoshino, Y.; Mukai, A.; Yazawa, K.; Uno, J.; Ando, A.; Mikami, Y.; Fukai, T.; Ishikawa, J.; Yamaguchi, K. Transvalencin Z, a new antimicrobial compound with salicylic acid residue from Nocardia transvalensis IFM 10065. J. Antibiot. 2004, 57, 803–807. [Google Scholar] [CrossRef]
- Nakouti, I.; Hobbs, G. A New approach to studying ion uptake by actinomycetes. J. Basic Microbiol. 2013. [Google Scholar] [CrossRef]
- Kallifidas, D.; Pascoe, B.; Owen, G.A.; Strain-Damerell, C.M.; Hong, H.J.; Paget, M.S. The zinc-responsive regulator Zur controls expression of the coelibactin gene cluster in Streptomyces coelicolor. J. Bacteriol. 2010, 192, 608–611. [Google Scholar] [CrossRef]
- Liu, N.; Wang, H.B.; Liu, M.; Gu, Q.; Zheng, W.; Huang, Y. Streptomyces alni sp. nov., a daidzein-producing endophyte isolated from a root of Alnus nepalensis D. Don. Int. J. Syst. Evol. Microbiol. 2009, 59, 254–258. [Google Scholar] [CrossRef]
- Wang, H.; Liu, N.; Xi, L.J.; Rong, X.Y.; Ruan, J.S.; Huang, Y. Genetic screening strategy for rapid access to polyether ionophore producers and products in actinomycetes. Appl. Environ. Microbiol. 2011, 77, 3433–3442. [Google Scholar]
- LB agar (1000 mL): tryptone (10 g, Bacto), yeast extract (5 g, Bacto), NaCl (10 g), and agar (15 g).
- PDA agar (1000 mL): fresh potato (200 g), glucose (20 g) and agar (15 g). Boil fresh potato for 20–30 min, and filter the juices with multi-layer gauzes. Use filtered juices to make PDA-agar medium.
- Shapiro, S.; Meier, A.; Guggenheim, B. The antimicrobial activity of essential oils and essential oil components toward oral bacteria. Oral Microbiol. Immunol. 1994, 9, 202–208. [Google Scholar] [CrossRef]
- Zhang, F.; Liu, S.C.; Lu, X.H.; Guo, L.D.; Zhang, H.; Che, Y.S. Allenyl and alkynyl phenyl ethers from the endolichenic fungus Neurospora terricola. J. Nat. Prod. 2009, 72, 1782–1785. [Google Scholar] [CrossRef]
© 2013 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).